vs
Moolec Science SA（MLEC）与奥驰亚（MO）财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是Moolec Science SA的2211.9倍（$5.8B vs $2.6M）。奥驰亚净利率更高（19.1% vs -91.8%，领先110.9%）
Moolec Science SA是一家专注于分子农业的农业生物技术与食品科技企业，通过改造作物平台生产可持续、高性价比的动物源蛋白，可应用于人造肉、乳制品及食品配料领域，服务全球多地的食品生产商与消费品品牌。
奥驰亚集团是美国头部烟草企业，通过旗下子公司生产销售可燃烟草与口服类烟草相关产品，核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草，以及on!口服尼古丁袋，产品主要供应批发商、分销商及大型零售客户。
MLEC vs MO — 直观对比
营收规模更大
MO
是对方的2211.9倍
$2.6M
净利率更高
MO
高出110.9%
-91.8%
损益表 — Q2 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.6M | $5.8B |
| 净利润 | $-2.4M | $1.1B |
| 毛利率 | -25.5% | 62.1% |
| 营业利润率 | -77.9% | 28.2% |
| 净利率 | -91.8% | 19.1% |
| 营收同比 | — | -2.1% |
| 净利润同比 | — | -63.2% |
| 每股收益（稀释后） | $-0.06 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLECMO
| Q4 25 | — | $5.8B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | — | $6.1B | ||
| Q1 25 | — | $5.3B | ||
| Q4 24 | $2.6M | $6.0B | ||
| Q3 24 | — | $6.3B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $5.6B |
净利润MLECMO
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $-2.4M | $3.0B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $2.1B |
毛利率MLECMO
| Q4 25 | — | 62.1% | ||
| Q3 25 | — | 62.8% | ||
| Q2 25 | — | 63.1% | ||
| Q1 25 | — | 61.8% | ||
| Q4 24 | -25.5% | 60.3% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 59.2% | ||
| Q1 24 | — | 58.8% |
营业利润率MLECMO
| Q4 25 | — | 28.2% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 52.9% | ||
| Q1 25 | — | 34.0% | ||
| Q4 24 | -77.9% | 48.2% | ||
| Q3 24 | — | 50.4% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 48.0% |
净利率MLECMO
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 39.1% | ||
| Q2 25 | — | 39.0% | ||
| Q1 25 | — | 20.5% | ||
| Q4 24 | -91.8% | 50.9% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 61.2% | ||
| Q1 24 | — | 38.2% |
每股收益（稀释后）MLECMO
| Q4 25 | — | $0.67 | ||
| Q3 25 | — | $1.41 | ||
| Q2 25 | — | $1.41 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | $-0.06 | $1.78 | ||
| Q3 24 | — | $1.34 | ||
| Q2 24 | — | $2.21 | ||
| Q1 24 | — | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | $4.5B |
| 总债务越低越好 | — | $25.7B |
| 股东权益账面价值 | $2.8M | $-3.5B |
| 总资产 | $31.4M | $35.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MLECMO
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | $1.9M | $3.1B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $3.6B |
总债务MLECMO
| Q4 25 | — | $25.7B | ||
| Q3 25 | — | $25.7B | ||
| Q2 25 | — | $24.7B | ||
| Q1 25 | — | $26.1B | ||
| Q4 24 | — | $24.9B | ||
| Q3 24 | — | $25.2B | ||
| Q2 24 | — | $25.0B | ||
| Q1 24 | — | $25.0B |
股东权益MLECMO
| Q4 25 | — | $-3.5B | ||
| Q3 25 | — | $-2.6B | ||
| Q2 25 | — | $-3.3B | ||
| Q1 25 | — | $-3.5B | ||
| Q4 24 | $2.8M | $-2.2B | ||
| Q3 24 | — | $-3.5B | ||
| Q2 24 | — | $-3.0B | ||
| Q1 24 | — | $-5.1B |
总资产MLECMO
| Q4 25 | — | $35.0B | ||
| Q3 25 | — | $35.0B | ||
| Q2 25 | — | $32.3B | ||
| Q1 25 | — | $35.8B | ||
| Q4 24 | $31.4M | $35.2B | ||
| Q3 24 | — | $34.2B | ||
| Q2 24 | — | $34.4B | ||
| Q1 24 | — | $36.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $3.3B |
| 自由现金流经营现金流 - 资本支出 | — | $3.2B |
| 自由现金流率自由现金流/营收 | — | 54.4% |
| 资本支出强度资本支出/营收 | 4.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 2.93× |
| 过去12个月自由现金流最近4个季度 | — | $9.1B |
8季度趋势，按日历期对齐
经营现金流MLECMO
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $205.0M | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $-75.0M | ||
| Q1 24 | — | $2.9B |
自由现金流MLECMO
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.0B | ||
| Q2 25 | — | $173.0M | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $-104.0M | ||
| Q1 24 | — | $2.8B |
自由现金流率MLECMO
| Q4 25 | — | 54.4% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 51.0% | ||
| Q4 24 | — | 55.1% | ||
| Q3 24 | — | 41.2% | ||
| Q2 24 | — | -1.7% | ||
| Q1 24 | — | 51.0% |
资本支出强度MLECMO
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 4.4% | 0.8% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.6% |
现金转化率MLECMO
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 0.09× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | -0.02× | ||
| Q1 24 | — | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLEC
暂无分部数据
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
